Department of Health Care Policy, Harvard Medical School, 180A Longwood Ave, Boston, MA 02115. Email:
Am J Manag Care. 2018 Mar;24(3):126-128.
The United States is simultaneously moving toward value-based payments for populations and precision medicine for individuals. During this evolution, innovations in payment and delivery that enhance tailoring of treatments to individuals while improving the value of care are needed. We propose one such innovation that would allow physician payment and patient cost sharing to better reflect the value of care by allowing the appropriateness of a service for a given patient in a given clinical situation to play a more meaningful role in the design of such incentives. We introduce the idea of a payment modifier, based on indication and appropriateness, and discuss its advantages and challenges to implementation.
美国正在同时朝着基于价值的人群支付和针对个体的精准医疗方向发展。在此演变过程中,需要在支付和交付方面进行创新,以增强针对个体的治疗定制,同时提高医疗服务的价值。我们提出了这样一种创新,通过允许服务对特定临床情况下特定患者的适宜性在这类激励措施的设计中发挥更有意义的作用,从而使医生的支付和患者的费用分担能够更好地反映医疗服务的价值。我们介绍了一种基于适应证和适宜性的支付调整因子的理念,并讨论了其实施的优势和挑战。